submit news    HOME | FEEDBACK  


- Bio/Medicine

- Chemicals

- Defense

- Drug Delivery

- Education

- Electronics

- Energy

- Events

- Grants

- Industry

- Investment

- Litigation

- Materials


- Nanofabrication

- Nanoparticles

- Nanotubes

- Optics

- Partnership

- Patent

- Products

- Quantum dots

- Research

- Smart Dust

- Software

- Browse by Month

- Current Shows

- Previous Shows

- Submit Events

Become A Nanotechwire Partner

FEI Company

Veeco Instruments

Nano Science and Technology Institute

National Nanotechnology Initiative

Nanotechnology at Zyvex

Want to see your Company or Organization listed above? Become A Nanotechwire Partner Today - click here


5/1/2009 8:06:26 AM
Bruker Corporation Reports First Quarter 2009 Results

Bruker Corporation today reported financial results for the first quarter ended March 31, 2009.

First Quarter 2009 Snapshot

  • GAAP Revenue decreased 3.3%
  • FX-Adjusted Revenue increased 4.5%
  • GAAP Net Income $8.4 million, EPS $0.05 per diluted share

Financial Results

In the first quarter of 2009, revenue was $230.5 million, a decrease of 3.3% compared to revenue of $238.3 in the first quarter of 2008. Excluding the effects of foreign currency translation, first quarter 2009 revenue increased by 4.5% year-over-year.

GAAP net income for the first quarter of 2009 was $8.4 million, or $0.05 per diluted share, compared to a net loss of ($0.8) million, or ($0.00) per diluted share, in the first quarter of 2008.

Free cash flow for the first quarter of 2009 was $9.2 million, compared to $8.9 million in the first quarter of 2008. During the first quarter of 2009, Bruker repaid $20.2 million of debt and ended the quarter with cash and cash equivalents of $149.9 million, and net debt of $53.7 million.

Comment and Outlook

Frank Laukien, President and CEO, commented: “We are pleased with our first quarter 2009 results, given the challenges in the marketplace today. During the first quarter, while we saw softness in our industrial and pharma/biotech orders, we recorded healthy orders from academic, medical school, government and other non-profit customers, which typically account for about two-thirds of Bruker’s revenue. While we continue to be below our gross margin and operating margin goals, we have started to see the effects of our cost-cutting initiatives and we expect to realize further savings in 2009. We continue to rationalize our cost structure, but we also are investing in new opportunities, and have introduced a record number of important new products so far in 2009.”

Dr. Laukien continued with an update on the outlook for 2009: “While certain industrial and pharma market segments this year are even more challenging than we had expected, our non-profit, governmental and other healthcare orders remain strong. For example, we are excited about our double-digit order growth in life-science mass spectrometry, driven by the compelling capabilities of our high-performance products. We also see positive signs as a result of the various international government stimulus packages, which in our opinion will particularly benefit high-end research equipment. In Japan, we have already seen additional orders and revenue, while elsewhere we have experienced a significant increase in requests for proposals and assistance with grant writing. We are hopeful that global stimulus funding for academic, medical and government research will result in additional business for Bruker in the second half of 2009 and into 2010.”

Bruker’s CFO, Bill Knight, added: “The downturn in the global economy is challenging to navigate and revenue was negatively affected by foreign currency headwinds in the first quarter. We continue to explore additional cost savings opportunities, while improving our operational efficiency through product design, production process improvements and enhanced balance sheet management.”

Other Headlines from Bruker Corporation ...
 - Bruker Announces $10M in New Orders for Novel Metrology Tools from Leading Semiconductor Manufacturer
 - Bruker Announces DektakXT, the New Standard in Stylus Profilometry
 - Bruker Introduces High Resolution Nanoelectrical and Electrochemical AFM Technology
 - Bruker’s New AcuityXR Technology Breaks Diffraction Limit
 - Bruker Completes Acquisition of the Atomic Force Microscopy and Optical Industrial Metrology Instruments Businesses from Veeco

More Industry Headlines ...
 - UCF Researcher Gets Global Attention, Cash
 - Scott Gish joins Cambridge NanoTech Executive Team
 - Ultratech Announces HB-LED Asia Technology Center in Taiwan
 - Luna Innovations Reports First Quarter 2011 Financial Results
 - CVD Equipment Corporation Announces Record Q1 Results

« Back To List »

- submit company
- submit news
- submit events
- advertise here

- More Events

Copyright © 2017 | Privacy Policy |